Literature DB >> 21736847

Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions.

Helen G Mulholland1, Liam J Murray, Lesley A Anderson, Marie M Cantwell.   

Abstract

Evidence is accumulating that vitamin D may be protective against carcinogenesis, although exceptions have been observed for some digestive tract neoplasms. The aim of the present study was to explore the association between dietary vitamin D and related nutrients and the risk of oesophageal adenocarcinoma and its precursor conditions, Barrett's oesophagus and reflux oesophagitis. In an all-Ireland case-control study conducted between March 2002 and July 2005, 218 oesophageal adenocarcinoma patients, 212 Barrett's oesophagus patients, 208 reflux oesophagitis patients and 252 population-based controls completed a 101-item FFQ, and provided lifestyle and demographic information. Multiple logistic regression analysis was applied to examine the association between dietary intake and disease risk. Oesophageal adenocarcinoma risk was significantly greater for individuals with the highest compared with the lowest tertile of vitamin D intake (OR 1·99, 95 % CI 1·03, 3·86; P for trend = 0·02). The direct association could not be attributed to a particular vitamin D food source. Vitamin D intake was unrelated to Barrett's oesophagus and reflux oesophagitis risk. No significant associations were observed for Ca or dairy intake and oesophageal adenocarcinoma, Barrett's oesophagus or reflux oesophagitis development. High vitamin D intake may increase oesophageal adenocarcinoma risk but is not related to reflux oesophagitis and Barrett's oesophagus. Ca and dairy product intake did not influence the development of these oesophageal lesions. These findings suggest that there may be population subgroups at an increased risk of oesophageal adenocarcinoma if advice to improve vitamin D intake from foods is implemented. Limited work has been conducted in this area, and further research is required.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21736847     DOI: 10.1017/S0007114511000742

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  17 in total

Review 1.  Vitamin D and Gastrointestinal Cancers: A Narrative Review.

Authors:  Hemant Goyal; Abhilash Perisetti; M Rubayat Rahman; Avi Levin; Giuseppe Lippi
Journal:  Dig Dis Sci       Date:  2018-12-03       Impact factor: 3.199

Review 2.  Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.

Authors:  Craig S Brown; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

3.  No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Authors:  Jing Dong; Puya Gharahkhani; Wong-Ho Chow; Marilie D Gammon; Geoffrey Liu; Carlos Caldas; Anna H Wu; Weimin Ye; Lynn Onstad; Lesley A Anderson; Leslie Bernstein; Paul D Pharoah; Harvey A Risch; Douglas A Corley; Rebecca C Fitzgerald; Prasad G Iyer; Brian J Reid; Jesper Lagergren; Nicholas J Shaheen; Thomas L Vaughan; Stuart MacGregor; Sharon Love; Claire Palles; Ian Tomlinson; Ines Gockel; Andrea May; Christian Gerges; Mario Anders; Anne C Böhmer; Jessica Becker; Nicole Kreuser; Rene Thieme; Tania Noder; Marino Venerito; Lothar Veits; Thomas Schmidt; Claudia Schmidt; Jakob R Izbicki; Arnulf H Hölscher; Hauke Lang; Dietmar Lorenz; Brigitte Schumacher; Rupert Mayershofer; Yogesh Vashist; Katja Ott; Michael Vieth; Josef Weismüller; Markus M Nöthen; Susanne Moebus; Michael Knapp; Wilbert H M Peters; Horst Neuhaus; Thomas Rösch; Christian Ell; Janusz Jankowski; Johannes Schumacher; Rachel E Neale; David C Whiteman; Aaron P Thrift
Journal:  Clin Gastroenterol Hepatol       Date:  2019-02-01       Impact factor: 11.382

Review 4.  Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence.

Authors:  Ryan Trowbridge; Sumeet K Mittal; Devendra K Agrawal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-05       Impact factor: 4.254

5.  Vitamin d receptor gene variants and esophageal adenocarcinoma risk: a population-based case-control study.

Authors:  C K Chang; H G Mulholland; M M Cantwell; L A Anderson; B T Johnston; A J McKnight; P D Thompson; R G P Watson; L J Murray
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 6.  Nutrition therapy issues in esophageal cancer.

Authors:  Keith R Miller; Matthew C Bozeman
Journal:  Curr Gastroenterol Rep       Date:  2012-08

Review 7.  Vitamin D and GI cancers: shedding some light on dark diseases.

Authors:  Laura Hargrove; Taylor Francis; Heather Francis
Journal:  Ann Transl Med       Date:  2014-01

8.  Predicting regression of Barrett's esophagus: results from a retrospective cohort of 1342 patients.

Authors:  Craig S Brown; Brittany Lapin; Chi Wang; Jay L Goldstein; John G Linn; Woody Denham; Stephen P Haggerty; Mark S Talamonti; John A Howington; Joann Carbray; Michael B Ujiki
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

9.  Vitamin D Receptor Polymorphisms Are Associated with Reduced Esophageal Vitamin D Receptor Expression and Reduced Esophageal Adenocarcinoma Risk.

Authors:  Vincent T Janmaat; Anouk Van De Winkel; Maikel P Peppelenbosch; Manon C W Spaander; André G Uitterlinden; Farzin Pourfarzad; Hugo W Tilanus; Agnieszka M Rygiel; Leon M G Moons; Pascal P Arp; Kausilia K Krishnadath; Ernst J Kuipers; Luc J W Van Der Laan
Journal:  Mol Med       Date:  2015-04-21       Impact factor: 6.354

10.  Serum 25-Hydroxyvitamin D Levels and the Risk of Dysplasia and Esophageal Adenocarcinoma in Patients with Barrett's Esophagus.

Authors:  Prashanthi N Thota; Gaurav Kistangari; Prabhdeep Singh; Linda Cummings; Kaveh Hajifathalian; Rocio Lopez; Madhusudhan R Sanaka
Journal:  Dig Dis Sci       Date:  2015-08-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.